Difference between revisions of "Spaeth EL, et al. PLoS ONE (2013) cited as Ref 502 in DOI: 10.1038/s41392-020-0110-5 (Q9765)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1371/annotation/4ab4c130-16cb-41f0-9507-b00ce070fbc6, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: Publication Date (P100): 2013, #quickstatements; #temporary_batch_1590002823654) |
||||||||||||||
Property / Publication Date | |||||||||||||||
+ | 2013
| ||||||||||||||
Property / Publication Date: 2013 / rank | |||||||||||||||
+ | Normal rank |
Revision as of 19:45, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Spaeth EL, et al. PLoS ONE (2013) cited as Ref 502 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Spaeth EL
0 references
2013
0 references